NCT05143255

Brief Summary

The proposed research is consistent with broader public health goals focused on improving communication regarding end-of-life care and the Centers for Medicare and Medicaid Services' (CMS) call for increased patient engagement in advance care planning (ACP) as part of standard care. The proposed study will address this public health issue by developing a communication-based intervention designed to improve Alzheimer's Disease and Related Dementias (ADRD) patients' and care partners' engagement in ACP, distress and care partner burden, and completion of advance directives and receipt of goal-concordant care at the end-of-life. Therefore, this study is aligned with the National Institute on Aging's long-term goal to improve the quality of care for ADRD patients and CMS's goal to increase engagement in ACP.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable alzheimer-disease

Timeline
Completed

Started Dec 2024

Shorter than P25 for not_applicable alzheimer-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 18, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

December 3, 2021

Completed
3 years until next milestone

Study Start

First participant enrolled

December 9, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 5, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 5, 2026

Completed
Last Updated

March 25, 2026

Status Verified

March 1, 2026

Enrollment Period

1.2 years

First QC Date

November 18, 2021

Last Update Submit

March 20, 2026

Conditions

Keywords

caregivingadvance care planningcommunication

Outcome Measures

Primary Outcomes (5)

  • Change in advance care planning preparedness, as measured by the Advance Care Planning Engagement Survey: Process Measures

    Change in advance care planning preparedness will be assessed in patients and care partners using the reliable and valid Advance Care Planning Engagement Survey: Process Measures (31-items). Response options range from 1=never to 5=a lot. Questions include those asking about knowledge of advance care planning, degree of contemplation about advance care planning, and self-efficacy and readiness to engage in advance care planning. Overall scores can range from 31 to 155, with higher scores indicating more engagement in advance care planning.

    Baseline, Post-Intervention (within 2 weeks), 3-month follow up

  • Change in patients' engagement in advance care planning, as measured by the Decision Maker subscale of the Advance Care Planning Engagement Survey: Action Measures

    Change in patient engagement in advance care planning will be assessed in patients using the reliable and valid Decision Maker (four items) subscale of the Advance Care Planning Engagement Survey: Action Measures. Response options range from 1=never to 5= a lot. Questions include those asking about whether patients have engaged in a decision around advance care planning (e.g., "Have you already decided who you want your medical decision maker to be?" Scores can range from 4 to 20, with higher scores indicating that more decisions have been made around advance care planning.

    Baseline, Post-Intervention (within 2 weeks), 3-month follow up

  • Change in care partners' engagement in advance care planning, as measured by the Van Scoy and Sudore measure which adapts the Decision Maker subscale of the Advance Care Planning Engagement Survey

    Change in care partner engagement in advance care planning will be assessed with a companion measure in the final phases of validation by Van Scoy and Sudore. This measure adapts the Advance Care Planning Engagement Survey to apply to care partners. Response options range from 1=never to 5=a lot. Scores can range from 4 to 20, with higher scores indicating more decisions have been made.

    Baseline, Post-Intervention (within 2 weeks), 3-month follow up

  • Change in discussion of advance directives

    Discussion of advance directives will be assessed with an 8-item measure that asks persons with ADRD and care partner whether the patient has discussed end-of-life care, living will, health care proxy, and DNR orders with family/patient and doctor/patient's doctor. Response options are yes or no. A total score is created by adding up the number of discussions, which can range from 0 to 8, with 0 meaning no discussions have occurred (low score) to 8, meaning all discussions have occurred (high score).

    Baseline, Post-Intervention (within 2 weeks), 3-month follow up

  • Change in the number of patients who have completed advance directives

    Completion of advance directives will be assessed by asking patients whether they have completed a do-not-resuscitate order, a living will, and/or or identified a health care proxy; data will be verified through the patient's electronic health record. Completion will be scored a 0 if the patient has completed none and 1 if they have completed one or more of the advance directives. Additional analyses will be done on each individual advance directive (e.g., 0 if no DNR order, 1 if yes to completing DNR order).

    Baseline, Post-Intervention (within 2 weeks), 3-month follow up

Secondary Outcomes (6)

  • Change in concordance on healthcare values, as measured by the Health Care Values Rating Scale

    Baseline, Post-Intervention (within 2 weeks), 3-month follow up

  • Change in perceived need for advanced care planning (ACP), as measured by the Decisional Balance scale

    Baseline, Post-Intervention (within 2 weeks), 3-month follow up

  • Change in psychological distress/depression, as measured by the Center for Epidemiological Studies Depression Scale

    Baseline, Post-Intervention (within 2 weeks), 3-month follow up

  • Change in psychological distress, as measured by the Hospital Anxiety and Depression Scale (HADS)

    Baseline, Post-Intervention (within 2 weeks), 3-month follow up

  • Change in communication quality, as measured by the Family Communication Subscale of the Cancer Communication Assessment Tool for Patients and Families (CCAT-PF)

    Baseline, Post-Intervention (within 2 weeks), 3-month follow up

  • +1 more secondary outcomes

Study Arms (1)

KNOW Intervention

EXPERIMENTAL
Behavioral: KNOW

Interventions

KNOWBEHAVIORAL

KNow the Optimal Way (KNOW) is a manualized ADRD patient-care partner intervention designed to increase engagement in advance care planning (ACP) and completion of advance directives among early stage ADRD patients and their care partners using theoretically grounded distress tolerance techniques (inhibitory learning theory) and communication skills (cognitive-social processing theory) consistent with recommended guidelines for discussions about ACP in ADRD care.

KNOW Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • not fluent in English;
  • ≤17 years of age;
  • too ill or weak to complete the interviews (per the interviewer);
  • presence of significant sensory, language, or motor deficit (e.g., visual or hearing loss, paralysis, aphasia) (per self report, the interviewer or medical record); or
  • patient is in the late stage of dementia (i.e., severe cognitive impairment), is bed-bound, or has a nursing home admission planned within 12 months per CP report or the medical record.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Weill Cornell Medicine

New York, New York, 10065, United States

Location

MeSH Terms

Conditions

Alzheimer DiseaseDementiaCommunication

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersBehavior

Study Officials

  • Sara Czaja, PhD

    Weill Medical College of Cornell University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 18, 2021

First Posted

December 3, 2021

Study Start

December 9, 2024

Primary Completion

February 5, 2026

Study Completion

February 5, 2026

Last Updated

March 25, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations